| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 12/13/2006 | CN1878761A Arylindenopyridines and arylindenopyridines and their use as adenosine A2a receptor antagonist |
| 12/13/2006 | CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors |
| 12/13/2006 | CN1876664A Organometallic complex and organic electroluminescent device using the same |
| 12/13/2006 | CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 12/13/2006 | CN1876647A Benzimidazole compound products |
| 12/13/2006 | CN1876646A Improved cinepazide maleate preparation method |
| 12/13/2006 | CN1289495C New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds |
| 12/13/2006 | CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1) |
| 12/13/2006 | CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 12/13/2006 | CN1289479C 5-cyclo indole compounds as 5-HT receptor ligands |
| 12/13/2006 | CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof |
| 12/13/2006 | CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 12/13/2006 | CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 12/13/2006 | CN1289466C Pharmaceutical compounds |
| 12/13/2006 | CN1289087C Quinoline derivatives as neuropeptide y antagonists |
| 12/13/2006 | CN1289086C Uses for anti-malarial therapeutic agents |
| 12/13/2006 | CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same |
| 12/12/2006 | US7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
| 12/12/2006 | US7148274 Heat and oxidation resistance; photostability for polymers |
| 12/12/2006 | US7148249 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
| 12/12/2006 | US7148242 N-formyl hydroxylamine compounds, compositions and methods of use |
| 12/12/2006 | US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 12/12/2006 | US7148235 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders |
| 12/12/2006 | US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 12/12/2006 | US7148230 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; 4-(3-chloro-2-fluoroanilino)-6-[1-(hydroxyacetyl)piperidin-4-yloxy]-7-methoxyquinazoline |
| 12/12/2006 | US7148224 Pyrazinone derivatives |
| 12/12/2006 | US7148221 Vanilloid receptor ligands and their use in treatments |
| 12/12/2006 | US7148214 Antihistaminic spiro compounds |
| 12/12/2006 | US7148029 Generating antibodies; quantitative analysis |
| 12/07/2006 | WO2006130736A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 12/07/2006 | WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity |
| 12/07/2006 | WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative |
| 12/07/2006 | WO2006129583A1 Pyrazolone derivative |
| 12/07/2006 | WO2006129432A1 Carboxamide compound and use thereof |
| 12/07/2006 | WO2006129199A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 12/07/2006 | WO2006129168A2 Bicyclic derivatives for the treatment of abnormal cell growth |
| 12/07/2006 | WO2006129120A2 Benzotriazepinone derivatives |
| 12/07/2006 | WO2006128815A1 Bicyclic 5-hydroxypyrazolines, method for producing the same and agents comprising the same |
| 12/07/2006 | WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| 12/07/2006 | WO2006128693A2 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system |
| 12/07/2006 | WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 12/07/2006 | WO2006128635A2 Method for producing n,n-bis(pyridin-2-yl-methyl)-1,1-bis(pyridin-2-yl)-1-aminoalkane compounds and metal complex salts containing these compounds |
| 12/07/2006 | WO2006100082A3 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 12/07/2006 | WO2006100081A3 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 12/07/2006 | WO2006099256A3 Modulators of atp-binding cassette transporters |
| 12/07/2006 | WO2006077584A3 New crystalline forms of aripiprazole |
| 12/07/2006 | WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| 12/07/2006 | WO2006014012A3 Aromatic compounds |
| 12/07/2006 | US20060276676 Non-symmetrical gelling agent |
| 12/07/2006 | US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/07/2006 | US20060276517 Non-systemic control of parasites |
| 12/07/2006 | US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38 |
| 12/07/2006 | US20060276514 Tyrosine kinase inhibitors |
| 12/07/2006 | US20060276509 Tripeptidyl peptidase inhibitors |
| 12/07/2006 | US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 12/07/2006 | US20060276487 New compounds useful for DPP-IV enzyme inhibition |
| 12/07/2006 | US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 12/07/2006 | US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |
| 12/07/2006 | US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy |
| 12/07/2006 | US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 12/07/2006 | US20060276450 Isoquinoline potassium channel inhibitors |
| 12/07/2006 | US20060276447 e.g. N-(2-Trifluoromethylphenyl)-N'-[(1-(6-trifluoromethyl-2-pyridyl)azetidin-3-yl)]urea; capsaicin receptor antagonist; analgesic, antiinflammatory agent; chronic, neuropathic, postoperative, postrheumatoid arthritic, osteoarthritic, back, visceral, cancer pain, algesia, neuralgia |
| 12/07/2006 | DE102005025728A1 Polymorphe von Polymorphs of 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester |
| 12/07/2006 | CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 12/07/2006 | CA2610491A1 Bicyclic derivatives for the treatment of abnormal cell growth |
| 12/07/2006 | CA2610456A1 3-methanesulfonylquinolines as gaba-b enhancers |
| 12/07/2006 | CA2610042A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 12/07/2006 | CA2609513A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 12/07/2006 | CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| 12/07/2006 | CA2608212A1 Novel piperidine carboxylic acid amide derivatives |
| 12/06/2006 | EP1728512A1 Controlled-leaching preparation and process for producing the same |
| 12/06/2006 | EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors |
| 12/06/2006 | EP1727816A1 Silylated carboxamides |
| 12/06/2006 | EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/06/2006 | EP1727811A1 New compounds for the inhibition of angiogenesis and use of thereof |
| 12/06/2006 | EP1727808A2 Biaryl amino acids and their use in dna binding oligomers |
| 12/06/2006 | EP1727805A1 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides |
| 12/06/2006 | EP1727800A1 Semicarbazide derivatives as kinase inhibitors |
| 12/06/2006 | EP1727799A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/06/2006 | EP1727796A2 Palladium catalyzed indolization of 2-bromo or chloroanilines |
| 12/06/2006 | EP1727794A1 Novel benzyl(idene)-lactam derivatives |
| 12/06/2006 | EP1727541A1 Imidazole-based hmg-coa reductase inhibitors |
| 12/06/2006 | EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 12/06/2006 | EP1505066B1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| 12/06/2006 | EP1438304B1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/06/2006 | EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 12/06/2006 | EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof |
| 12/06/2006 | EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same |
| 12/06/2006 | EP1210086B1 Use of halofuginone for treating urethral stricture |
| 12/06/2006 | CN1875026A Platinum complex and luminescent element |
| 12/06/2006 | CN1875017A Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound |
| 12/06/2006 | CN1875016A 咪唑衍生物 Imidazole derivatives |
| 12/06/2006 | CN1875015A Benzo [b][1,4] dioxepine derivatives |
| 12/06/2006 | CN1874775A 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (VR1) for the treatment of pain |
| 12/06/2006 | CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 12/06/2006 | CN1872850A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 12/06/2006 | CN1288152C 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
| 12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 12/06/2006 | CN1288138C 4,5-disubstituted-1,8-naphthoyl imide compounds and use thereof |